$CLDX Roth Capital Reiterates Buy On Celldex Following 2Q14 Results, Keeps $40 PT http://www.smarteranalyst.com/2014/08/08/roth-capital-reiterates-buy-on-celldex-following-2q14-results-keeps-40-pt/